SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 29, Issue 9, 2011, Pages 1099-1100

Clinical research: Show us the data

(3) Ocana, Alberto a,b Amir, Eitan a Seruga, Bostjan c

a PRINCESS MARGARET HOSPITAL (Canada)

b HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE (Spain)

c INSTITUTE OF ONCOLOGY (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; CETUXIMAB;

CARDIOPULMONARY ARREST; CARDIOTOXICITY; CLINICAL RESEARCH; DRUG INFORMATION; DRUG SAFETY; HEALTH PRACTITIONER; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL EDUCATION; MEDICAL LITERATURE; NOTE; PRIORITY JOURNAL;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DATA COLLECTION; HUMANS; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 79952768920 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2010.33.1462 Document Type: Note

Times cited : (9)

References (9)

1
- 0035733719
- Show me the data!
- Perou CM: Show me the data! Nat Genet 29:373, 2001
- (2001) Nat Genet , vol.29 , pp. 373
- Perou, C.M.¹

2
- 33947498821
- Eligibility criteria of randomized controlled trials published in high-impact general medical journals: A systematic sampling review
- Van Spall HG, Toren A, Kiss A, et al: Eligibility criteria of randomized controlled trials published in high-impact general medical journals: A systematic sampling review. JAMA 297:1233-1240, 2007
- (2007) JAMA , vol.297 , pp. 1233-1240
- Van Spall, H.G.¹ Toren, A.² Kiss, A.³

3
- 32144433159
- Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
- DOI 10.1056/NEJMoa053422
- Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567-578, 2006 (Pubitemid 43209104)
- (2006) New England Journal of Medicine , vol.354 , Issue.6 , pp. 567-578
- Bonner, J.A.¹ Harari, P.M.² Giralt, J.³ Azarnia, N.⁴ Shin, D.M.⁵ Cohen, R.B.⁶ Jones, C.U.⁷ Sur, R.⁸ Raben, D.⁹ Jassem, J.¹⁰ Ove, R.¹¹ Kies, M.S.¹² Baselga, J.¹³ Youssoufian, H.¹⁴ Amellal, N.¹⁵ Rowinsky, E.K.¹⁶ Ang, K.K.¹⁷

4
- 84855619267
- US Food and Drug Administration: Prescribing information for cetuximab. http://www.accessdata.fda.gov/drugsatfda-docs/label/2009/125084s167lbl.pdf
- Prescribing Information for Cetuximab

5
- 37449028688
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-Month analysis of the ATAC trial
- Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group
- Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group, Forbes JF, Cuzick J, et al: Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9:45-53, 2008
- (2008) Lancet Oncol , vol.9 , pp. 45-53
- Forbes, J.F.¹ Cuzick, J.²

6
- 84855625573
- US Food and Drug Administration: Prescribing information for anastrozole. http:// www.accessdata.fda.gov/drugsatfda-docs/label/2009/020541s024s025lbl.pdf
- Prescribing Information for Anastrozole

7
- 0022771308
- Supplementary analysis at the conclusion of a sequential clinical trial
- Whitehead J: Supplementary analysis at the conclusion of a sequential clinical trial. Biometrics 42:461-471, 1986
- (1986) Biometrics , vol.42 , pp. 461-471
- Whitehead, J.¹

8
- 0041885405
- Colon cancer survival is associated with increasing number of lymph nodes analyzed: A secondary survey of intergroup trial INT-0089
- DOI 10.1200/JCO.2003.05.062
- Le Voyer TE, Sigurdson ER, Hanlon AL, et al: Colon cancer survival is associated with increasing number of lymph nodes analyzed: A secondary survey of intergroup trial INT-0089. J Clin Oncol 21:2912-2919, 2003 (Pubitemid 46621841)
- (2003) Journal of Clinical Oncology , vol.21 , Issue.15 , pp. 2912-2919
- Le, V.T.E.¹ Sigurdson, E.R.² Hanlon, A.L.³ Mayer, R.J.⁴ Macdonald, J.S.⁵ Catalano, P.J.⁶ Haller, D.G.⁷

9
- 54449083092
- Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of radiation therapy oncology group protocol 9413
- Taussky D, Bae K, Bahary JP, et al: Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of radiation therapy oncology group protocol 9413. Urology 72:1125-1129, 2008
- (2008) Urology , vol.72 , pp. 1125-1129
- Taussky, D.¹ Bae, K.² Bahary, J.P.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.